Fate Therapeutics, Inc. short interest in 2021
In 2021, Fate Therapeutics, Inc.'s disclosed short interest ran from 11.64% of shares outstanding on 15 Jan 2021 to 12.04% on 31 Dec 2021, a change of +0.40 percentage points. The year's high was 14.02% on 30 Apr 2021 and its low 10.62% on 15 Nov 2021, averaging 12.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.34 days on 28 May 2021. Full history: Fate Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 11.64% (15 Jan 2021)
- End of year
- 12.04% (31 Dec 2021)
- Change
- +0.40 pp
- High
- 14.02% (30 Apr 2021)
- Low
- 10.62% (15 Nov 2021)
- Average
- 12.32%
- Highest days to cover
- 19.34 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 11.64% | 7.58 | |
| 29 Jan 2021 | 11.55% | 10.29 | |
| 12 Feb 2021 | 11.04% | 14.89 | |
| 26 Feb 2021 | 11.81% | 10.55 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 13.26% | 12.39 | |
| 31 Mar 2021 | 13.82% | 11.21 | |
| 15 Apr 2021 | 13.83% | 14.41 | |
| 30 Apr 2021 | 14.02% | 17.90 | |
| 14 May 2021 | 13.85% | 12.32 | 10-Q filed, results (8-K) |
| 28 May 2021 | 12.94% | 19.34 | |
| 15 Jun 2021 | 12.53% | 9.59 | |
| 30 Jun 2021 | 12.59% | 12.22 | |
| 15 Jul 2021 | 12.38% | 12.61 | |
| 30 Jul 2021 | 13.00% | 16.43 | |
| 13 Aug 2021 | 12.95% | 18.13 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 12.54% | 7.24 | |
| 15 Sep 2021 | 12.39% | 12.17 | |
| 30 Sep 2021 | 11.97% | 11.70 | |
| 15 Oct 2021 | 11.30% | 12.16 | |
| 29 Oct 2021 | 10.82% | 9.79 | |
| 15 Nov 2021 | 10.62% | 13.62 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 11.37% | 11.65 | |
| 15 Dec 2021 | 11.33% | 7.48 | |
| 31 Dec 2021 | 12.04% | 8.20 |
See also: Fate Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.